Parallax Volatility Advisers, L.P. Seagen Inc. Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $3.07 Million - $3.46 Million	16,005 New	16,005 $3.4 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $397,297 - $471,090	3,385 New	3,385 $435,000
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $3,988 - $4,754	28 New	28 $5,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $1,994 - $2,377	-14 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $1,891 - $2,255	14 New	14 $2,000
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $468,771 - $650,437	-3,409 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $24,201 - $33,580	176 Added 5.44%	3,409 $473,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $532,248 - $685,169	3,233 New	3,233 $566,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.